Viewing nowAlendronate Sodium 150 mg (Sodium Alendronate 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Yooyoung Pharmaceutical Co., Ltd.

MFDS item code 201001731 · Notified 2010.02.26 · Insurance code 648203310
Treatment and prevention of osteoporosis in postmenopausal women
This medication is used for the treatment and prevention of osteoporosis in postmenopausal women.
1. Adults : Administer 150 mg of risedronate sodium orally once a month. 2. Older adults : No dose adjustment is necessary because the bioavailability and pharmacodynamics of this medicine in older adults (over 60 years) are similar to those in younger people. 4. Patients with renal impairment : No dose adjustment is necessary in patients with creatinine clearance of 30 mL/min or greater. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30 mL/min. ○ Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before the first food or beverage other than water of the day. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take a dose on the scheduled dosing day, follow these instructions. - If the next scheduled dosing day is 7 days or more away, take 1 tablet the next morning after remembering. Take the next dose again on the originally scheduled dosing day. Do not take more than 1 tablet of this medicine within 7 days. - If the next scheduled dosing day is within 7 days, wait until the originally scheduled dosing day and then take 1 tablet of this medicine.
Safety and efficacy have not been established in children under 18 years.
This medication may irritate the gastrointestinal mucosa, so caution is needed for those with upper gastrointestinal disorders. In particular, patients with esophageal diseases, gastritis, duodenitis, or ulcers should consult a doctor before taking this medication. It is essential to take this medication with a sufficient amount of water, and the patient should not lie down for at least 30 minutes after taking it. This medication should not be administered to patients with certain esophageal abnormalities, hypocalcemia, women who are pregnant or may become pregnant, or patients with severe renal impairment. Additionally, individuals with lactose intolerance should not take this medication. It is important to maintain adequate intake of calcium and vitamin D while on this medication, and caution should be exercised when taking it with drugs containing divalent cations such as calcium or magnesium, as absorption may be hindered. If symptoms such as esophagitis, dysphagia, chest pain, or heartburn occur during use, the patient should immediately stop taking the medication and consult a doctor. Long-term use may rarely lead to side effects such as fractures or osteonecrosis of the jaw, so regular check-ups are necessary. The administration of this medication during pregnancy or breastfeeding should be avoided or done according to a doctor's guidance. Safety has not been established for use in children, so it is advisable not to use this medication in pediatric patients. In case of overdose, serum calcium and phosphate levels may decrease, and prompt medical attention should be sought.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air from entering and kept at a temperature between 1°C and 30°C. Storing it this way helps maintain the drug's efficacy and prevents degradation.
Bright blue oval film-coated tablet
1 tablet (1 tablet/PTP packaging X 1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Yooyoung Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.